Shoreline Venture Management

Shoreline Venture Management is a long-established early-stage venture capital firm founded in 1998 and headquartered in San Francisco, California, with a second operational base in Vancouver, British Columbia. The firm focuses on Western North America — from San Diego to Vancouver — deliberately looking beyond the Bay Area to back strong technology centers with deep talent pipelines. Shoreline invests at the intersection of data and technology applied to the enterprise and healthcare, with target verticals including enterprise software, mobile, cloud and application management, big data, security, and healthcare IT and diagnostics. Initial checks range from $250,000 to $8 million, with Shoreline actively following on and bringing in co-investors as portfolio companies scale. The firm has raised multiple funds, including Shoreline Venture Partners Fund II and Fund III. Managing Directors Peter Craddock and co-founder Bob Spears lead a team of approximately 12, backed by CFO Keith Corbin and a deep Venture Partner bench spanning the US, UK, and Canada. The portfolio spans roughly 20 companies with notable public exits including BuildDirect, which listed on the TSX Venture Exchange in August 2021, and ARYx Therapeutics, which listed on NASDAQ at a $175 million market cap, as well as 8 acquisitions. Shoreline's durability since 1998 reflects a consistent thesis: capital-efficient enterprise and healthcare technology companies built outside Silicon Valley, where founder talent is equally strong but competition for deals is lower. The firm's dual San Francisco-Vancouver base gives it a natural bridge across the Pacific Northwest technology corridor.